Anna Richo Joins Illumina's Board of Directors
Anna Richo Joins Illumina's Board of Directors
Ms. Richo brings more than 30 years of global legal, compliance, and regulatory experience to Illumina's Board
Richo 女士擁有超過 30 年的全球法律、合規和監管經驗 致Illumina董事會
SAN DIEGO, May 20, 2024 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN) announced today that Anna Richo has joined the company's Board of Directors following shareholder approval of the director slate at the company's May 16, 2024, annual meeting. Ms. Richo currently serves as Corporate Senior Vice President, Strategic Advisor to the General Counsel and CEO at Cargill, Inc. a global food production and agricultural company.
聖地亞哥，2024年5月20日 /PRNewswire/ — Illumina, Inc.（納斯達克股票代碼：ILMN）今天宣佈，在公司2024年5月16日的年會上股東批准董事名單後，安娜·裏喬已加入公司董事會。Richo 女士目前擔任全球食品生產和農業公司嘉吉公司的企業高級副總裁、總法律顧問兼首席執行官的戰略顧問。
Ms. Richo brings more than 30 years of regulated-industry experience as an attorney and legal executive, with extensive experience in compliance and business ethics, intellectual property, and corporate litigation. She formerly served as Corporate Senior Vice President, General Counsel, Chief Compliance Officer, and Corporate Secretary at Cargill, where she oversaw the company's corporate governance, global ethics and compliance, global security, global government relations, law, and shareholder relations functions.
Richo女士擁有超過30年的受監管行業從業經歷，擔任律師和法律主管，在合規和商業道德、知識產權和公司訴訟方面擁有豐富的經驗。她曾在嘉吉擔任公司高級副總裁、總法律顧問、首席合規官和公司秘書，負責監督公司的公司治理、全球道德與合規、全球安全、全球政府關係、法律和股東關係職能。
Prior to joining Cargill, Ms. Richo was Executive Vice President and General Counsel at UCB, a biopharmaceutical company based in Belgium. She also served as Senior Vice President and Chief Compliance Officer at Amgen, a global biotechnology company, and as Chief Litigation Counsel, Associate General Counsel, and Vice President of Law at Baxter Healthcare.
在加入嘉吉之前，Richo 女士曾在總部位於比利時的生物製藥公司 UCB 擔任執行副總裁兼總法律顧問。她還曾在全球生物技術公司安進擔任高級副總裁兼首席合規官，並在百特醫療擔任首席訴訟顧問、副總法律顧問和法律副總裁。
"I am thrilled to welcome Anna to our Board of Directors," said Jacob Thaysen, CEO of Illumina. "In today's evolving business and regulatory environment, her extensive global legal, compliance, and regulatory experience, including at biotechnology, biopharmaceutical, and medtech companies, will enhance our evaluation and understanding of the risks and opportunities associated with Illumina's expanding worldwide operations."
Illumina首席執行官雅各布·塞森說：“我很高興歡迎安娜加入我們的董事會。”“在當今不斷變化的商業和監管環境中，她豐富的全球法律、合規和監管經驗，包括在生物技術、生物製藥和醫療技術公司的經驗，將增強我們對與Illumina全球業務擴張相關的風險和機遇的評估和理解。”
Ms. Richo also serves as a member of Exelon's Board of Directors, as a member of the Cargill Foundation Board of Directors, on the Board of Trustees for DePaul University, and on the Children's Minnesota Governance Board.
Richo 女士還擔任 Exelon 董事會成員、嘉吉基金會董事會成員、德保羅大學董事會成員和明尼蘇達州兒童組織管理委員會成員。
Ms. Richo holds a B.S. in Industrial and Labor Relations from Cornell University and a J.D. from DePaul University College of Law.
Richo 女士擁有康奈爾大學勞資關係學士學位和德保羅大學法學院法學博士學位。
About Illumina
關於 Ilumina
Illumina is improving human health by unlocking the power of the genome. Our focus on innovation has established us as a global leader in DNA sequencing and array-based technologies, serving customers in the research, clinical, and applied markets. Our products are used for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments. To learn more, visit www.illumina.com and connect with us on X(Twitter), Facebook, LinkedIn, Instagram, TikTok, and YouTube.
Investors:
Salli Schwartz
858-291-6421
IR@illumina.com
投資者：
Salli Schwartz
858-291-6421
IR@illumina.com
Media:
Bonny Fowler
740-641-5579
PR@illumina.com
媒體：
邦尼·福勒
740-641-5579
PR@illumina.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/anna-richo-joins-illuminas-board-of-directors-302150329.html
SOURCE Illumina, Inc.
來源 Illumina, Inc.